Ternary complex formation and reduced folate in surgical specimens of human adenocarcinoma tissues
- 15 January 1993
- Vol. 71 (2) , 471-480
- https://doi.org/10.1002/1097-0142(19930115)71:2<471::aid-cncr2820710231>3.0.co;2-w
Abstract
Background and Methods. Various factors, including thymidylate synthase, thymidine kinase, 5-fluorouracil phosphorylation and degradation pathways, folate concentrations, and the stability of ternary complex, which influence thymidylate synthase inhibition rate of fluoropyrimdines, were studied in 87 human adenocarcinoma tissues. Results. The activity of the 5-fluorouracil degradation pathway was not significantly lower than the activity of the 5-fluorouracil phosphorylation pathway. The activity of the catabolism pathway of 5-fluorouracil should be considered in human adenocarcinoma tissue during chemotherapy. On the other hand, the means plus or minus standard deviations (means ± SD) of the concentration of 5,10-methylenetetrahydrofolate and tetrahydrofolate were 0.69 ± 0.54 and 1.25 ± 0.69 nM, respectively, for the adenocarcinoma tissues without previous chemotherapy. Conclusions. Because the half-life of tritium-labeled ternary complex and folate concentration in cytosol were correlated well, the differences in folate concentration among tumors must influence the dynamic equilibrium of ternary complex formation. Moreover, these results show that the ratio of 5,10-methylenetetrahydrofolate concentration to thymidylate synthase concentration influences the thymidylate synthase inhibition rate in tumor, and that the new synthesis of 5,10-methylenetetrahydrofolate and tetrahydrofolate from other endogenous reduced folates is also important in tumors with high thymidylate synthase concentrations.Keywords
This publication has 20 references indexed in Scilit:
- Treatment of patients with advanced colorectal cancer with cisplatin, 5-fluorouracil, and leucovorinCancer, 1991
- 5-fluorouracil and uft-sensitive gastric carcinoma has a high level of thymidylate synthaseCancer, 1990
- Low-Dose Continuous Infusion 5-Fluorouracil and CisplatinAmerican Journal of Clinical Oncology, 1989
- Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenografTBiochemical Pharmacology, 1989
- Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Proceedings of the National Academy of Sciences, 1986
- Folate utilization in friend erythroleukemia cellsJournal of Cellular Physiology, 1983
- The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenograftsEuropean Journal of Cancer and Clinical Oncology, 1982
- Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetasePharmacology & Therapeutics, 1981
- Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetaseBiochemical Pharmacology, 1981
- Increased thymidylate synthetase in 5-fluorodeoxyuridine resistant cultured hepatoma cellsBiochemical Pharmacology, 1980